Invention Grant
US08193150B2 Improving vascular function with an inactivating mutant of a TRPC channel protein
失效
用TRPC通道蛋白的失活突变体改善血管功能
- Patent Title: Improving vascular function with an inactivating mutant of a TRPC channel protein
- Patent Title (中): 用TRPC通道蛋白的失活突变体改善血管功能
-
Application No.: US13217755Application Date: 2011-08-25
-
Publication No.: US08193150B2Publication Date: 2012-06-05
- Inventor: Carsten Struebing
- Applicant: Carsten Struebing
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Priority: EP05000440 20050112
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/00
Abstract:
The invention refers to the use of a TRPC channel, an inactivating mutant thereof, or a nucleotide sequence coding for the TRPC channel or for the inactivating mutant for the production of a medicament for the treatment of a cardiovascular disease and a method of screening a modulator of the TRPC channel or an inactivating mutant thereof.
Public/Granted literature
- US20110312874A1 USE OF A TRPC CHANNEL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE Public/Granted day:2011-12-22
Information query
IPC分类:
